Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-04-18
2010-10-05
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07807681
ABSTRACT:
The present invention relates to novel compounds for inhibiting the urokinase plasminogen activator (uPA), which have high bioavailability and oral administerability, and also to the use thereof as therapeutic active compounds for the treatment of urokinase- or/and urokinase receptor-associated disorders such as, for example, tumors and metastasizing. The invention relates in particular to compounds containing hydroxyamidine or hydroxyguanidine groups.
REFERENCES:
patent: 7211670 (2007-05-01), Ziegler et al.
patent: 2003 205 498 (2003-09-01), None
patent: 1639142 (2005-07-01), None
patent: 1 182 207 (2002-02-01), None
patent: WO 00/17158 (2000-03-01), None
patent: 2002/063303 (2002-08-01), None
patent: WO 03/072559 (2003-09-01), None
patent: WO 2004/011449 (2004-02-01), None
Kobayashi, et al., The Protease Inhibitor Bikunin, a Novel Anti-Metastatic Agent, Biol. Chem., vol. 384, 749-54, (2003).
Cecil Textbook of Medicine, 21th Edition (2001), Goldman & Bennett (Editors), W. B. Saunders Company (Publisher), Chapter 198, Principles of Cancer Therapy, pp. 1060-1074.
http://www.healthline.com/galecontent/giant-cell-tumors. Accessed Aug. 2007.
Stürzebecher et al.: 3- Amidinophenylalanine-based Inhibitors of Urokinase, Bioorganic & Medicinal Chemistry Letters, vol. 9, 1999, pp. 3147-3152.
Mullins, D. E. and S. T. Rohlich: “The role of proteinases in cellular invasiveness”, Biochem. Biophys. Acta, vol. 695, pp. 177-214, 1983.
Grant, M. B. and C. Guay: “Plasminogen activator production by human retinal endothelial cells of nondiabetic and diabetic origin”, Invest. Ophthalmol. Vis. Sci., vol. 32, pp. 53-64, 1991.
Kanse, S. M. et al.: “Induction of vascular smooth muscle cell proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders”, Arterioscler. Thromb. Vasc. Biol, vol. 12, pp. 2848-2854,1997.
Fraki, J. E. et al.: Correlation of epidermal plasminogen activator activity in psoriasis, Br. J. Dermatol., vol. 108, pp. 39-44,1983.
Wilkinson, J. E et al.: “Role of plasminogen activator in pemphigus vulgaris”, Am. J. Pathol. vol. 134, pp. 561-569, 1989.
Schaefer, B. M. et al.: Plasminogen activation in bullous pemphigoid immunohistology reveals urokinase type plasminogen activator, its receptor and plasminogen activator inhibitor type-2, in lesional epidermis , Autoimmunity 23, 155-164,1996.
Airola, K. et al.: “Urokinase plasminogen activator is expressed by basal keratinocytes before interstitial collagenase, strmelysisn-1 and laminin-5 in experimentally induced dermatitis herpetiformes lesions”, J. Invest. Dermatol., vol. 108, pp. 7-11, 1997.
Preissner, K. T. et al.: “Molecular crosstalk between adhesion receptors and proteolytic cascades in vascular remodeling”, Thromb Haemost., vol. 78, No. 1, pp. 88-95, 1997.
May, A. M. et al.: “Urokinase receptor (CD87) regulates leukocyte recruitment via beta2-integrins in vivo”, J. Exp. Med., vol. 188, pp. 1029-1037, 1998.
Künzel et al., “4-Amidinobenzylamine-Based Inhibitors of Urokinase”, Bioorganic & Medicinal Chemistry Letters, vol. 12, 2002, p. 645-648).
Buergle Markus
Clement Bernd
Schmalix Wolfgang
Sperl Stefan
Wosikowski Katja
Arnold Gianna J.
Leeser Erich A
Miles & Stockbridge P.C.
Wilex AG
Wilson James O
LandOfFree
Hydroxyamidine and hydroxyguanidine compounds as urokinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxyamidine and hydroxyguanidine compounds as urokinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxyamidine and hydroxyguanidine compounds as urokinase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4151172